Open access
Aug 2026
Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025
Overall, ASH 2025 suggests a shift from achieving gene editing to quantifying efficacy, durability, and safety, with standardized biomarker frameworks likely to play an increasingly important role in future clinical translation.
Ze-Zhou Zang, Wei Zheng, Rui-Rong Xu et al.
· Biomarker Research · 0 citations